Oppenheimer is upgrading Centene Corporation CNC to Outperform from Underperform and updating its 2010 and 2011 EPS estimates to $1.82 and $2.01 from $1.80 and $2.00, respectively.
It is also increasing its price target to $28 from $18.
CNC is trading higher at $22.24
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorUpgradesPrice TargetAnalyst RatingsHealth CareManaged Health CareOppenheimer
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in